Todd E Rasmussen Selected Research

Vascular System Injuries

1/2021	Temporary intravascular shunt use improves early limb salvage after extremity vascular injury.
9/2017	Systemic anticoagulation in the setting of vascular extremity trauma.
2/2015	VA Vascular Injury Study (VAVIS): VA-DoD extremity injury outcomes collaboration.
2/2015	The American Association for the Surgery of Trauma PROspective Observational Vascular Injury Treatment (PROOVIT) registry: multicenter data on modern vascular injury diagnosis, management, and outcomes.
4/2014	Endovascular Skills for Trauma and Resuscitative Surgery (ESTARS) course: curriculum development, content validation, and program assessment.
6/2011	The epidemiology of vascular injury in the wars in Iraq and Afghanistan.
1/2011	The impact of ischemic intervals on neuromuscular recovery in a porcine (Sus scrofa) survival model of extremity vascular injury.
7/2010	Outcomes of selective tibial artery repair following combat-related extremity injury.
9/2009	A national survey of evolving management patterns for vascular injury.
9/2009	Effect of temporary shunting on extremity vascular injury: an outcome analysis from the Global War on Terror vascular injury initiative.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Todd E Rasmussen Research Topics

Disease

57	Wounds and Injuries (Trauma) 11/2022 - 10/2003
21	Hemorrhage 01/2022 - 07/2011
15	Vascular System Injuries 01/2021 - 04/2005
9	Shock 01/2022 - 09/2011
7	Hemorrhagic Shock 01/2020 - 09/2011
6	Heart Arrest (Cardiac Arrest) 06/2022 - 03/2013
6	Ischemia 01/2017 - 07/2010
4	Thrombosis (Thrombus) 09/2017 - 06/2007
3	Exsanguination 06/2022 - 01/2020
3	Stroke (Strokes) 01/2021 - 08/2002
3	Inflammation (Inflammations) 02/2017 - 05/2002
3	Reperfusion Injury 02/2017 - 11/2012
2	Infections 11/2022 - 06/2007
2	Hypovolemia 06/2022 - 04/2021
2	Pathologic Constriction (Stenosis) 05/2020 - 06/2009
2	Gunshot Wounds (Gunshot Wound) 01/2020 - 09/2009
2	Nonpenetrating Wounds 10/2018 - 01/2018
2	Blast Injuries 01/2017 - 11/2016
2	Compartment Syndromes 01/2016 - 01/2015
2	Hypothermia 08/2012 - 02/2002
2	Acidosis 11/2011 - 02/2002
2	Aneurysm (Aneurysms) 09/2009 - 09/2004
2	Abdominal Aortic Aneurysm 02/2005 - 05/2002
1	Hypertension (High Blood Pressure) 01/2021
1	Arteriovenous Fistula 12/2020
1	Fistula 12/2020
1	Thoracic Outlet Syndrome (Syndrome, Thoracic Outlet) 05/2020
1	Brain Injuries (Brain Injury) 01/2019
1	Abdominal Injuries 01/2018
1	Necrosis 02/2017
1	Chronic Traumatic Encephalopathy 01/2017
1	Soft Tissue Injuries (Soft Tissue Injury) 01/2017
1	False Aneurysm (Pseudoaneurysm) 02/2016
1	War-Related Injuries 02/2016
1	Critical Illness (Critically Ill) 12/2015
1	Multiple Trauma (Multiple Injuries) 02/2015
1	Traumatic Amputation (Traumatic Amputations) 08/2013
1	Pulmonary Embolism 08/2013
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2013
1	Intraoperative Complications 11/2012

Drug/Important Bio-Agent (IBA)

5	Explosive Agents (Explosives)IBA 01/2020 - 04/2005
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2012
2	Creatine Kinase (Creatine Phosphokinase)IBA 02/2017 - 11/2012
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2017 - 11/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2017 - 10/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 06/2013 - 11/2011
2	Tranexamic Acid (AMCA)FDA Link 03/2013 - 02/2012
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	Troponin IIBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2019
1	Polymethyl Methacrylate (Sol)IBA 10/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	2- amino- 3- cyano- 6- ethyl- 5- (4- pyridyl)pyridineIBA 01/2018
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 02/2017
1	Biological ProductsIBA 01/2017
1	Amyl NitriteIBA 02/2016
1	Matrix Metalloproteinases (MMPs)IBA 10/2015
1	Interleukin-6 (Interleukin 6)IBA 10/2014
1	4- azido- 7- phenylpyrazolo- (1,5a)- 1,3,5- triazineIBA 08/2013
1	Indicators and Reagents (Reagents)IBA 03/2013
1	Fibrinogen (Factor I)FDA Link 03/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2012
1	TEMPOIBA 06/2011

Therapy/Procedure

20	Resuscitation 01/2022 - 02/2002
14	Catheters 02/2021 - 02/2005
11	Surgical Amputation (Amputations) 10/2020 - 04/2005
10	Limb Salvage 11/2022 - 04/2007
9	Ligation 01/2021 - 01/2011
7	Endovascular Procedures 01/2020 - 04/2005
5	Tourniquets 12/2020 - 06/2006
5	Therapeutics 01/2018 - 09/2009
5	Vascular Surgical Procedures 02/2015 - 04/2007
3	Thoracotomy 10/2018 - 09/2011
3	Critical Care (Surgical Intensive Care) 07/2017 - 07/2006
2	Heart Massage 06/2022 - 04/2021
2	Blood Transfusion (Blood Transfusions) 01/2019 - 09/2014
2	Length of Stay 09/2017 - 10/2003
2	Ostomy 11/2016 - 12/2012
2	Fasciotomy 01/2016 - 01/2015
2	Colostomy 06/2014 - 12/2012
2	Airway Management 12/2012 - 08/2012
2	Stents 06/2009 - 03/2005
2	Negative-Pressure Wound Therapy 04/2009 - 11/2006
1	Precision Medicine 01/2022
1	Endovascular Aneurysm Repair 01/2021
1	Renal Dialysis (Hemodialysis) 12/2020
1	Central Venous Catheters 12/2020
1	Decompression 05/2020
1	Surgical Decompression 05/2020
1	Splenectomy 01/2020
1	Extracorporeal Membrane Oxygenation 01/2020
1	Oxygenators 01/2020
1	Myocutaneous Flap 02/2017
1	Contraindications 05/2014
1	Vena Cava Filters (Inferior Vena Cava Filter) 08/2013
1	Personal Protective Equipment 01/2013
1	Tertiary Prevention 01/2013
1	Secondary Prevention 01/2013
1	Vascularized Composite Allotransplantation 11/2012